Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date

3152 results found

2025 ∙ Rahimi, H. K. Jasim, A. A. Rezahosseini, O. Harboe, Z. B.

Immunogenicity and adverse effects of pneumococcal vaccines co-administered with influenza or SARS-CoV-2 vaccines in adults: A systematic review and Meta-analysis

  • Adults
  • Older adults
  • Pneumococcal disease
  • Influenza
  • COVID-19
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Low
2025 ∙ Niyati, R. Rezahosseini, O. Ekenberg, C. Larsen, C. S. Harboe, Z. B.

Immunogenicity and Safety of Pneumococcal Vaccines Co-Administered with Common Travel Vaccines in Adults: A Systematic Review +

  • Adults
  • Older adults
  • Pneumococcal disease
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Low
2025 ∙ Terekhov, R. P. Svotin, A. A. Korochkina, M. D. Khodyachikh, A. A. Varnavskiy, M. A. Piniaeva, A. N. Ivin, Y. Y. Zhdanov, D. D. Kozlovskaya, L. I. Taldaev, A.

Immunogenicity and safety of polio vaccines in infants: a systematic review of randomized clinical trials

  • Newborn
  • Poliomyelitis
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Low
2025 ∙ Montes-Sevilla, L. D. Hernandez-Montes, P. E. Ramirez-Garcia, E. Guzman-Rios, E. D. Flores-Reyes, M. F. Acosta-Gutierrez, G. H. Morales-Hernandez, O. Giron-Perez, M. I.

Immunogenicity and safety of tetravalent dengue vaccines: a systematic review of clinical trials

  • Adults
  • Older adults
  • Dengue
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Chen, Z. Wan, C. Chen, B. Mo, Q. Ju, M. Deng, K. Li, X. Qin, D.

Immunogenicity and safety of the booster COVID-19 vaccine among people with HIV: a systematic review and meta-analysis

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Yuan, Y. Wang, T. Xia, Y. Shi, Z. He, P.

Immunogenicity and safety of the domestic and imported live-attenuated varicella vaccine in healthy Chinese populations: a systematic review and meta-analysis

  • Western Pacific
  • China
  • Newborn
  • Children
  • Adolescents
  • Adults
  • Varicella
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Ngamprasertchai, T. Ruenroengbun, N. Kajeekul, R.

Immunogenicity and Safety of the Higher-Valent Pneumococcal Conjugate Vaccine vs the 13-Valent Pneumococcal Conjugate Vaccine in Older Adults: A Systematic Review and Meta-analysis of Randomized Controlled Trials

  • Adults
  • Older adults
  • Pneumococcal disease
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Low
2025 ∙ Martins, A. M. Valero Juan, L. F. Santos, M. Martins, J. P.

Immunogenicity as a Predictor of Influenza Vaccine Efficacy: A Systematic Review

  • Children
  • Adolescents
  • Adults
  • Older adults
  • Influenza
  • Efficacy/effectiveness
  • Modeling
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Pacheco-Haro, M. D. de Arenas-Arroyo, S. N. Diaz-Goni, V. Velasco-Lucio, E. J. Castellares-Gonzalez, C. I. Reynolds-Cortez, V. Simeon-Prieto, A. Ignateva, E. Martinez-Vizcaino, V.

Immunogenicity of a 20-Valent Pneumococcal Conjugate Vaccine Versus a 13-Valent Vaccine in Infants: A Systematic Review and Meta-Analysis

  • Newborn
  • Pneumococcal disease
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
High
2025 ∙ Ballivian, J. Parker, E. P. K. Berrueta, M. Ciapponi, A. Argento, F. Bardach, A. Brizuela, M. Castellana, N. Comande, D. Kampmann, B. Mazzoni, A. Sambade, J. M. Stegelmann, K. Xiong, X. Munoz, F. M. Stergachis, A. Buekens, P.

Immunogenicity of COVID-19 Vaccines During Pregnancy A Systematic Review and Comparison of Pregnant Versus Nonpregnant Persons

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Low
Loading...